Skip to content

Postmarket Study of JUVÉDERM VOLBELLA™ With Lidocaine in the Lips

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01629134
Enrollment
62
Registered
2012-06-27
Start date
2012-06-30
Completion date
2012-12-31
Last updated
2014-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lip Augmentation

Brief summary

A prospective, multicenter postmarket study of the use of JUVÉDERM VOLBELLA™ with Lidocaine in the lips.

Interventions

All treatments are carried out according to the physician's experience and the Directions for Use

Sponsors

Allergan Medical
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Desire and willingness for correction of asymmetry or volume enhancement of his/her lips * Females and males ≥ 18 years of age * Have established a realistic treatment goal that the Physician agrees is achievable, i.e., have realistic expectations of aesthetic results

Exclusion criteria

* Not fulfilling the standard prescribing criteria for JUVÉDERM VOLBELLA™ with Lidocaine as detailed in the Directions for Use * Have a condition or be in a situation that, in the Physician's opinion, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study

Design outcomes

Primary

MeasureTime frameDescription
Subject Rating of the Natural Look and Feel of the Lips4 weeksPercentage of subjects rating the look and feel of their lips as being extremely natural, very natural, slightly natural, and not natural.
Injector Rating of the Natural Look and Feel of the Lips4 weeksPercentage of injectors who rated the look and feel of subjects' lips as being extremely natural, very natural, slightly natural, and not natural.

Secondary

MeasureTime frameDescription
Ease of Injection15 minutes after injectionInjectors rated the ease of injection on a scale ranging from 0 (Very easy) to 10 (Extremely difficult)
Malleability of Product15 minutes after injectionInjectors rated the malleability on a scale ranging from 0 (Extremely malleable/Not hard to mold) to 10 (Not malleable/Hard to mold)
Need for Massage15 minutes after injectionInjectors rated whether none/minimal, a little, some, or a lot of massage was required to optimize placement of VOLBELLA
Bruising of the Lips15 minutes after injectionInjector assessment of whether there was none, little, some, moderate, or considerable bruising in subjects' lips
Comparative Rating With Previous Treatment15 minutes after injectionSubject rating of lip improvement with VOLBELLA compared with previous lip enhancement treatments as significantly better, somewhat better, no difference, somewhat worse, or significantly worse
Rating of Injection Discomfort15 minutes after injectionThe level of discomfort during treatment on a scale of 0 (no discomfort) to 10 (extreme discomfort).
Return to Social Engagement4 weeksTime to return to normal daily activities
Swelling of the Lips15 minutes after injectionInjector assessment of whether there was none, little, some, moderate, or considerable swelling in subjects' lips

Countries

Germany

Participant flow

Participants by arm

ArmCount
Volbella
Subjects treated with JUVÉDERM VOLBELLA™ according to the physician's experience and Directions for Use Crosslinked hyaluronic acid gel : All treatments are carried out according to the physician's experience and the Directions for Use
62
Total62

Baseline characteristics

CharacteristicVolbella
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
3 Participants
Age, Categorical
Between 18 and 65 years
59 Participants
Age, Continuous39.7 years
STANDARD_DEVIATION 12.6
Region of Enrollment
Germany
62 participants
Sex: Female, Male
Female
55 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 62
serious
Total, serious adverse events
0 / 62

Outcome results

Primary

Injector Rating of the Natural Look and Feel of the Lips

Percentage of injectors who rated the look and feel of subjects' lips as being extremely natural, very natural, slightly natural, and not natural.

Time frame: 4 weeks

Population: All subjects who met the criteria and treatment was initiated

ArmMeasureGroupValue (NUMBER)
VolbellaInjector Rating of the Natural Look and Feel of the LipsExtremely natural45.9 Percentage of subjects
VolbellaInjector Rating of the Natural Look and Feel of the LipsVery natural54.1 Percentage of subjects
VolbellaInjector Rating of the Natural Look and Feel of the LipsSlightly natural0 Percentage of subjects
VolbellaInjector Rating of the Natural Look and Feel of the LipsNot natural0 Percentage of subjects
Primary

Subject Rating of the Natural Look and Feel of the Lips

Percentage of subjects rating the look and feel of their lips as being extremely natural, very natural, slightly natural, and not natural.

Time frame: 4 weeks

Population: All subjects who met the criteria and treatment was initiated

ArmMeasureGroupValue (NUMBER)
VolbellaSubject Rating of the Natural Look and Feel of the LipsExtremely natural52.5 Percentage of subjects
VolbellaSubject Rating of the Natural Look and Feel of the LipsVery natural35.6 Percentage of subjects
VolbellaSubject Rating of the Natural Look and Feel of the LipsSlightly natural11.9 Percentage of subjects
VolbellaSubject Rating of the Natural Look and Feel of the LipsNot natural0 Percentage of subjects
Secondary

Bruising of the Lips

Injector assessment of whether there was none, little, some, moderate, or considerable bruising in subjects' lips

Time frame: 15 minutes after injection

Population: All subjects who met the criteria and treatment was initiated

ArmMeasureGroupValue (NUMBER)
VolbellaBruising of the LipsNone85.5 Percentage of subjects
VolbellaBruising of the LipsLittle12.9 Percentage of subjects
VolbellaBruising of the LipsSome1.6 Percentage of subjects
VolbellaBruising of the LipsModerate0 Percentage of subjects
VolbellaBruising of the LipsConsiderable0 Percentage of subjects
Secondary

Comparative Rating With Previous Treatment

Subject rating of lip improvement with VOLBELLA compared with previous lip enhancement treatments as significantly better, somewhat better, no difference, somewhat worse, or significantly worse

Time frame: 15 minutes after injection

Population: All subjects who met the criteria and treatment was initiated

ArmMeasureGroupValue (NUMBER)
VolbellaComparative Rating With Previous TreatmentSignificantly better46.2 Percentage of subjects
VolbellaComparative Rating With Previous TreatmentSomewhat better53.8 Percentage of subjects
VolbellaComparative Rating With Previous TreatmentNo difference0 Percentage of subjects
VolbellaComparative Rating With Previous TreatmentSomewhat worse0 Percentage of subjects
VolbellaComparative Rating With Previous TreatmentSignificantly worse0 Percentage of subjects
Secondary

Ease of Injection

Injectors rated the ease of injection on a scale ranging from 0 (Very easy) to 10 (Extremely difficult)

Time frame: 15 minutes after injection

Population: All subjects who met the criteria and treatment was initiated

ArmMeasureGroupValue (NUMBER)
VolbellaEase of InjectionScore of 054.8 Percentage of subjects
VolbellaEase of InjectionScore of 145.2 Percentage of subjects
Secondary

Malleability of Product

Injectors rated the malleability on a scale ranging from 0 (Extremely malleable/Not hard to mold) to 10 (Not malleable/Hard to mold)

Time frame: 15 minutes after injection

Population: All subjects who met the criteria and treatment was initiated

ArmMeasureGroupValue (NUMBER)
VolbellaMalleability of ProductScore of 045.2 Percentage of subjects
VolbellaMalleability of ProductScore of 154.8 Percentage of subjects
Secondary

Need for Massage

Injectors rated whether none/minimal, a little, some, or a lot of massage was required to optimize placement of VOLBELLA

Time frame: 15 minutes after injection

Population: All subjects who met the criteria and treatment was initiated

ArmMeasureGroupValue (NUMBER)
VolbellaNeed for MassageNone/minimal41.9 Percentage of subjects
VolbellaNeed for MassageA little58.1 Percentage of subjects
VolbellaNeed for MassageSome0 Percentage of subjects
VolbellaNeed for MassageA lot0 Percentage of subjects
Secondary

Rating of Injection Discomfort

The level of discomfort during treatment on a scale of 0 (no discomfort) to 10 (extreme discomfort).

Time frame: 15 minutes after injection

Population: All subjects who met the criteria and treatment was initiated

ArmMeasureValue (MEAN)Dispersion
VolbellaRating of Injection Discomfort1.3 scale scoreStandard Deviation 1.5
Secondary

Return to Social Engagement

Time to return to normal daily activities

Time frame: 4 weeks

Population: All subjects who met the criteria and treatment was initiated

ArmMeasureGroupValue (NUMBER)
VolbellaReturn to Social Engagement4-5 Days8.2 Percentage of subjects
VolbellaReturn to Social Engagement< 1 Day (same day)62.3 Percentage of subjects
VolbellaReturn to Social Engagement1 Day (next day)19.7 Percentage of subjects
VolbellaReturn to Social Engagement2-3 Days9.8 Percentage of subjects
VolbellaReturn to Social Engagement> 6 Days0 Percentage of subjects
Secondary

Swelling of the Lips

Injector assessment of whether there was none, little, some, moderate, or considerable swelling in subjects' lips

Time frame: 15 minutes after injection

Population: All subjects who met the criteria and treatment was initiated

ArmMeasureGroupValue (NUMBER)
VolbellaSwelling of the LipsNone38.7 Percentage of subjects
VolbellaSwelling of the LipsLittle53.2 Percentage of subjects
VolbellaSwelling of the LipsSome8.1 Percentage of subjects
VolbellaSwelling of the LipsModerate0 Percentage of subjects
VolbellaSwelling of the LipsConsiderable0 Percentage of subjects

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026